Bremer Bank National Association Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bremer Bank National Association decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,180 shares of the healthcare conglomerate’s stock after selling 76 shares during the quarter. Bremer Bank National Association’s holdings in UnitedHealth Group were worth $1,103,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Delta Financial Group Inc. lifted its position in UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares during the last quarter. First PREMIER Bank lifted its position in UnitedHealth Group by 7.0% in the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 18 shares during the last quarter. Genesee Capital Advisors LLC lifted its position in UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC lifted its position in UnitedHealth Group by 2.2% in the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the last quarter. Finally, Matrix Private Capital Group LLC lifted its position in UnitedHealth Group by 3.6% in the second quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 19 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH opened at $510.03 on Monday. The company has a market cap of $469.37 billion, a P/E ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s fifty day moving average price is $549.37 and its 200-day moving average price is $563.18.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.